A Randomized Controlled Trial, Comparing the efficacy of Unani Drugs Kachnar, Muqil, Darchini, and Aftimoon with mifepristone in the management of Uterine Fibroid

INTERVENTION: Intervention1: Powder of Kachnar, Muqil, Darchini, Aftimoon: 4.5gm Powder of Kachnar,Muqil,Darchini,Aftimoon twice a day for 3 consecutive months Intervention2: Powder of Kachnar, Muqil, Darchini, Aftimoon and Tab. Mifepristone: 4.5gm Powder of Kachnar,Muqil,Darchini,Aftimoon twice a day and Tab Mifepristone 10mg once a day for 3 consecutive months Control Intervention1: Tab. Mifepristone: Tab. Mifepristone 10mg once a day for 3 consecutive months CONDITION: Health Condition 1: N858‐ Other specified noninflammatory disorders of uterus PRIMARY OUTCOME: Reduction in the size of Uterine Fibroid, To be confirmed through Ultrasonography ; Timepoint: Assessment of all parameters at initiation of study at 0 day then follow up of every 15th day for 3 consecutive months SECONDARY OUTCOME: Improvement in sign and symptoms ; Improvement in PBAC Score ; Improvement in Hb levelsTimepoint: Assessment of all parameters at initiation of study at 0 day then follow up of every 15th day for 3 consecutive months INCLUSION CRITERIA: Married and Unmarried females complaining of abnormal uterine bleeding, non cyclical pelvic pain, dyspareunia, diagnosed with symptomatic cases of uterine fibroid, measuring less than or equal to 3cm and PBAC score of 100 to 300,and are willing to participate and signed the informed consent